渗出性糖尿病视网膜病变。使用氯贝丁酯以减少但延长的剂量治疗硬性渗出物数年（作者译）
[Exudative diabetic retinopathy. The use of clofibrate in the treatment of hard exudates using a reduced but prolonged dosage over several years (author's transl)].
作者信息
Dorne P A
出版信息
Arch Ophtalmol (Paris). 1977;37(5):393-400.
PMID:144477
Abstract
Clofibrate is the treatment of choice in exudative diabetic retinopathy. With a low dose the exudates disappear, on the condition to carry on the treatment during several years. 1 or 2 capsules a day (500 or 1 000 mg/day) is enough. At this dose the tolerance is very good, allowing a regular and non-stop treatment.
摘要
氯贝丁酯是渗出性糖尿病视网膜病变的首选治疗药物。低剂量使用时，渗出物会消失，但前提是要持续治疗数年。每天服用1或2粒胶囊（500或1000毫克/天）就足够了。在此剂量下，耐受性非常好，可以进行规律且不间断的治疗。
Zotero 插件